AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients - Jung, Susanne; Nelde, Annika; Maringer, Yacine; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Özbek, Melek; Martus, Peter; Hackenbruch, Christopher; Englisch, Alexander; Heitmann, Jonas S.; Salih, Helmut R.; et al. (Frontiers in Oncology, 2024)